BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2985406)

  • 1. Adrenergic hyposensitivity during long-term diuretic therapy--a possible explanation for the antihypertensive effect of diuretics?
    Middeke M; Remien J; Kirzinger S; Holzgreve H
    Eur J Pharmacol; 1985 Mar; 109(3):401-3. PubMed ID: 2985406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorthalidone: the forgotten diuretic.
    Kountz DS; Goldman A; Mikhail J; Ezer M
    Postgrad Med; 2012 Jan; 124(1):60-6. PubMed ID: 22314115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diuretics on adrenergic receptors in the rat.
    Brørs O; Sandnes D
    Pharmacol Toxicol; 1989 Oct; 65(4):249-51. PubMed ID: 2587507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and hemodynamic effects of ticrynafen compared with hydrochlorothiazide.
    Huang CM; Chock D; del Greco F; Armstrong M; Kroc J; Quintanilla A
    Nephron; 1979; 23 Suppl 1():51-6. PubMed ID: 381956
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
    Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic responsiveness is regulated selectively in hypertension.
    Feldman RD; Freeman DJ; Bierbrier GS; Anthony SE; Brown JE
    Clin Pharmacol Ther; 1993 Dec; 54(6):654-60. PubMed ID: 8275620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
    Hainer JW; Sugg J
    Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study with clorexolone: an oral hypotensive and diuretic.
    Verbov JL; Tunstall-Pedoe DS; Cooke TJ
    Br J Clin Pract; 1966 Jul; 20(7):351-60. PubMed ID: 5940967
    [No Abstract]   [Full Text] [Related]  

  • 13. Atenolol-induced regulation of leukocyte beta 2-adrenoceptors in hypertension.
    Piantanelli L; Giunta S; Basso A; Cognini G; Andreoni A; Paciaroni E
    Pharmacology; 1984; 29(4):210-4. PubMed ID: 6093157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticrynafen, a uricosuric antihypertensive diuretic.
    Stote RM; Dubb JW; Familiar RG; Alexander F
    Clin Pharmacol Ther; 1978 Apr; 23(4):456-60. PubMed ID: 630794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension.
    Uzu T; Kimura G
    Circulation; 1999 Oct; 100(15):1635-8. PubMed ID: 10517735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
    Mugellini A; Nieswandt V
    Expert Opin Pharmacother; 2012 Dec; 13(18):2699-709. PubMed ID: 23170938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Saluretic-diuretic and hypotensive effect of hypothiazide in hypertension].
    Kunitsa LD
    Sov Med; 1970 Dec; 33(12):115-7. PubMed ID: 5516931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.